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Introduction
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer mortality [1] . Increased red blood cell count (Erythrocytosis) is an important paraneoplastic phenomenon in HCC patients [2] [3] [4] [5] . Erythrocytosis generally leads to elevated blood viscosity Sun et 
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X-100) for 15 min on ice. Nuclei were collected in buffer containing 1 µM EDTA, 0.5 µM EGTA and 10 µM Tris. Chromatin was sonicated, incubated with rabbit polyclonal antibody against HIF-2α (1 µg, Novus NB100-122) and precipitated with protein G Sepharose (GE Healthcare, Freiburg, Germany). Eluted DNA was purified with QIAquick Extraction Kit (Qiagen, Hilden, Germany). HRE-containing region of the EPO enhancer was amplified and analysed using agarose gel electrophoresis. Following primers were used [19] : forward, 5'-TCG TTT TCT GGG AAC CTC CA -3'; reverse, 5'-GGA GCC ACC TTA TTG ACC AG-3'.
Assay of EPO and TGF-β1
The concentrations of EPO and TGF-β1 in cell-culture supernatants were measured by enzyme-linked immunosorbent assays (Quantikine IVD ELISA Kit, R&D Systems, Wiesbaden, Germany).
MTT assay
The cell viability was determined using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT, Sigma-Aldrich, Seelze, Germany) assay. Cells were incubated with MTT solution (5 g/l) for 2 hours at 37°C and then lysed with MTT lysis buffer (10 % SDS, 1 % HCl, 0.46 % isopropanol). The optical density was detected with a microplate reader (Thermo Scientific, Bonn, Germany) at 570 nm.
Statistical analysis
Data are shown as means ± standard error (SEM). Statistical comparison between two groups was performed by two-tailed Student's t-or Mann-Whitney-test, as applicable. Differences were considered significant when P < 0.05. All statistics were calculated using GraphPad Prism 5 (GraphPad Software, Witzenhausen, Germany).
Results and Discussion

PHD2 promotes EPO production and HNF-4α expression in HepG2 cells
HepG2 cells were transiently transfected with siRNA against PHD2. The knockdown efficiency was determined using immunoblotting (Fig. 1A) . As shown in Fig. 1B and 1C , PHD2 knockdown led to a marked reduction of EPO mRNA and EPO secretion. 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay showed that the viability of PHD2 knockdown cells was not impaired at this time point (Fig. 4) .
The expression of EPO in hepatocytes was reported to be maintained by the transcription factor HNF-4α [20, 21] . As shown in Fig. 1D and 1E, the levels of both HNF-4α mRNA and protein were reduced in PHD2 knockdown cells. These results indicate that PHD2 promotes the EPO production by HepG2 cells by maintaining the expression of HNF-4α.
PHD2 maintains HNF-4α expression in HepG2 cells by inhibiting TGF-β1 signalling
We attempted to study the mechanism by which PHD2 maintains HNF-4α expression. The expression of HNF-4α in hepatocytes was shown to be inhibited by TGF-β1 [22] . We confirmed the inhibitory effect of TGF-β1 on HNF-4α expression in HepG2 cells ( Fig. 2A, 2B ). TGF-β1 is a secreted protein ubiquitiously expressed in humans and functions in an auto-/ paracrine manner [23] . As shown in Fig. 3A , the expression of TGF-β1 in HepG2 cells was significantly up-regulated by PHD2 knockdown. The concentration of secreted TGF-β1 was also elevated (Fig. 3B) . The expression of TGF-β receptor 1 (TGF-βR1), the most important receptor subtype for TGF-β1 [24] , was also up-regulated in the PHD2 knockdown cells (Fig.  3C) . TGF-β1 neutralizing antibody attenuated the effect of PHD2 on HNF-4α expression (Fig.  3D) . TGF-β1 pathway has been shown to inhibit cell proliferation [24] . As shown in Fig. 4 , the viability of PHD2 knockdown cells was significantly lower than the control cells 96 hours after transfection, which was in line with the up-regulation of TGF-β1 and TGF-β receptor 1 expression 48 hours after transfection. These data suggest that the down-regulation of HNF-4α expression in the PHD2 knockdown HepG2 cells was the consequence of up-regulation of TGF-β1 and TGF-β1 receptor expression, and the following activation of the auto-/paracrine signalling of TGF-β1. In the murine osteosarcoma cell line LM8, PHD2 was also observed to 
Normalised EPO/L28 (B) and HNF-4α/ L28 (D) ratios are shown (mean ± SEM, n = 3; *P < 0.05, Student´s t-test). C: 72 h after transfection, the concentration of EPO in the cellculture supernatants was analysed using ELISA detection (mean ± SEM, n = 4; *P < 0.05, Mann-Whitneytest).
Fig. 2.
TGF-β1 suppresses HNF-4α expression. A: HepG2 cells were incubated with or without TGF-β1 for 24 h. HNF-4α was detected by immunoblotting. Lamin A was used as loading control. The results are representative for 3 independent experiments. B: HepG2 cells were incubated with or without TGF-β1 (10 ng/ml) for 24 h. Total mRNA was analysed for HNF-4α and ribosomal protein L28 mRNA expression by qPCR. Normalised HNF-4α/L28 ratios are shown (mean ± SEM, n = 3). Fig. 3 . PHD2 influences the activity of TGF-β1 pathway. A+C: HepG2 cells were transfected with water (WT), non-specific siRNA (neg.Control) or siRNA against PHD2 (siPHD2). 48 h after transfection, total mRNA was analysed for TGF-β1, TGF-β receptor 1 (TGF-βR1) and ribosomal protein L28 mRNA expression by qPCR. Normalised TGF-β1/L28 (A) and TGF-βR1/L28 (C) ratios are shown (mean ± SEM, n = 3; *P < 0.05, Student´s t-test). B: HepG2 cells were transfected with non-specific siRNA (Control) or siRNA against PHD2 (siPHD2). 48 h after transfection, the concentration of TGF-β1 in the cell-culture supernatants was analysed using ELISA detection (mean ± SEM, n = 6; *P < 0.05, Student's t-test). D: HepG2 cells were transfected with non-specific siRNA or siRNA against PHD2 (siPHD2). 24 h after transfection, TGF-β1 neutralizing antibody was added. After 24 h further incubation, total mRNA was analysed for HNF-4α and ribosomal protein L28 mRNA expression by qPCR. Normalised HNF-4α/L28 ratios are shown (mean ± SEM, n = 3; *P < 0.05, Student´s t-test).
Fig. 4.
Influence of PHD2 on cell viability. HepG2 cells were transfected with non-specific siRNA (Control) or siRNA against PHD2 (siPHD2). 48 h or 96 h after transfection, cell viability was analyzed using MTT assay (mean ± SEM, n = 5-6; *P < 0.05, ns: not significant, Student´s t-test). Sun 
in normoxic HepG2 cells (data not shown). As shown in Fig. 5C , PHD2 knockdown did not cause a detectable accumulation of HIF-2α protein in normoxic HepG2 cells. In chromatin immunoprecipitation (ChIP) assay, an increased binding of HIF-2α to the EPO enhancer was not observed in PHD2 knockdown HepG2 cells (Fig. 5D) . In HIF-2α knockdown cells, PHD2 knockdown also caused a significant down-regulation of EPO expression (Fig. 5B) . These data indicate that HIF-2α does not play a major role in the regulation of EPO expression by PHD2. We could not exclude the possibility that the accumulation of HIF-2α could not be detected due to insufficient sensitivity of immunoblotting and ChIP. However, even if some HIF-2α accumulates in PHD2 knockdown cells, the effect of HIF-2α accumulation on EPO expression is probably less important than the effect of HNF-4α down-regulation.
In conclusion, we show that PHD2 promotes the EPO biosynthesis in the human HCC cell line HepG2 by inactivating TGF-β1 pathway. Selective inhibition of PHD2 in HCC cells using liver-specific gene therapy techniques (e.g. mediated by adeno-associated viral gene transfer vectors) might be considered as a new way to manage erythrocytosis in HCC patients. Since no specific PHD2 inhibitor has been characterized, we were not able to confirm our results by inhibiting PHD2 pharmacologically. Hepatitis B virus was observed to interact with TGF-β1/HNF-4α axis [29] . Since HepG2 is the only well-established EPO-producing HCC cell line without viral infection [30] , all our experiments were performed with this cell line. In vivo experiments and isolation of novel EPO-producing HCC cell lines would be -2α) . 48 h after transfection, cells were incubated in hypoxia for 2 h. HIF-2α was detected by immunoblotting. Actin was used as loading control. The results are representative for 3 independent experiments. B: HepG2 cells were transfected with non-specific siRNA (Control) or siRNA against HIF-2α (siHIF-2α). 24 h after transfection, cells were transfected with water (WT), non-specific siRNA (neg.Control) or siRNA against PHD2 (siPHD2). After 24 h further incubation, total mRNA was analysed for EPO and ribosomal protein L28 mRNA expression by qPCR. Normalised EPO/ L28 ratios are shown (mean ± SEM, n = 3; *P < 0.05, Student´s t-test). C+D: HepG2 cells were transfected with non-specific siRNA (neg.Control) or siRNA against PHD2 (siPHD2). 48 h after transfection, HIF-2α was detected by immunoblotting. Lamin A was used as loading control (A). The binding of HIF-2α to the EPO enhancer was detected using ChIP (B). Hypoxia (Hox, 24h 1% O 2 ) was used as a positive control. The results are representative for 3 independent experiments.
